News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

i3 Statprobe Selected to Assume Bulk of Eli Lilly and Company (LLY)'s U.S. Data Management Work


8/8/2008 10:31:26 AM

ANN ARBOR, Mich.--(BUSINESS WIRE)--Pharmaceutical services company i3 announced today that global pharmaceutical firm Eli Lilly and Company (NYSE: LLY) is transferring the majority of its U.S. data management work to i3 Statprobe, a leader in clinical data services, as part of Lilly’s ongoing effort to transform its business. This significantly expands the business relationship between the two organizations.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES